Supplementary Figure 2: Rapamycin treatment restored the fertility of nonbreeding male NMRs. (A) TEM was used
to visualise Leydig cells from breeding and nonbreeding male NMRs. (B) Quantification of the autophagosomes (arrows) shown in (A) (n = 6 in each group). (C and D) Quantification of testosterone (P = 0.0002910) and LH (P = 0.006257) concentrations in nonbreeding male NMRs (n = 6 in each group), which were IP injected with the control or rapamycin. Data are presented as means±SEM. (E) HE staining was used to visualise sperm maturation status from breeding and nonbreeding male NMRs. (F) Quantification of the mature sperms shown in (E) (n = 6 in each group) (breeding males vs nonbreeding males in naive group, P = 0.0146, breeding males vs nonbreeding males in DMSO group, P = 0.0007713, breeding males in naive group vs in rapamycin group, P = 0.0203, breeding males vs nonbreeding males in rapamycin group, P = 0.001995, breeding males in naive group vs nonbreeding males in rapamycin group, P = 0.02839, breeding males in DMSO group vs nonbreeding males in rapamycin group, P = 0.0001150, nonbreeding males in DMSO group vs in rapamycin group, P = 0.0005040) (G) Quantification of testes weights from breeding and nonbreeding male NMRs under different treatment (n = 6 in each group)( breeding males vs nonbreeding males in naive group, P = 0.009860, breeding males vs nonbreeding males in DMSO group, P = 0.02905, breeding males in naive group vs in rapamycin group, P = 0.02927, breeding males vs nonbreeding males in rapamycin group, P = 0.0001300, nonbreeding males in naive group vs in rapamycin group, P = 0.0001310, breeding males in DMSO group vs nonbreeding males in rapamycin group, P = 0.004080, nonbreeding males in DMSO group vs in rapamycin group, P = 0.009300), which were IP injected with the control or rapamycin. Data are presented as means ± SEM.
